Algo version: 0.98b
GMAB is listed at the NASDAQ Exchange
GMAB [GMAB]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is GMAB stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

On Friday 21st of November 2014, Genmab AS had a stock price of $4.70. If you invested back then, your return now would be a profit of $15.75 per share or 335.11%

Yes, the average daily trading liquidity for Genmab AS is $21.63 million. You should therefore be able to get in and out of your positions relatively fast.

Genmab AS has no real debt, which is good in periods of high inflation. Genmab AS has a very good net profit margin of 23.47% and should have very high tolerances against inflation.

We have calculated the inflation risk for Genmab AS to be low [0.3 out of 1]